CN104407077B - 一种mes,nhs残留的hplc检测方法 - Google Patents
一种mes,nhs残留的hplc检测方法 Download PDFInfo
- Publication number
- CN104407077B CN104407077B CN201410839225.6A CN201410839225A CN104407077B CN 104407077 B CN104407077 B CN 104407077B CN 201410839225 A CN201410839225 A CN 201410839225A CN 104407077 B CN104407077 B CN 104407077B
- Authority
- CN
- China
- Prior art keywords
- mes
- hydroxysuccinimide
- residual
- detection method
- hplc detection
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000001514 detection method Methods 0.000 title claims abstract description 35
- 238000004128 high performance liquid chromatography Methods 0.000 title claims abstract description 22
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical group OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims abstract description 45
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims abstract description 18
- 239000000463 material Substances 0.000 claims abstract description 18
- 239000008363 phosphate buffer Substances 0.000 claims abstract description 16
- 239000003960 organic solvent Substances 0.000 claims abstract description 13
- 239000000741 silica gel Substances 0.000 claims abstract description 4
- 229910002027 silica gel Inorganic materials 0.000 claims abstract description 4
- NQTADLQHYWFPDB-UHFFFAOYSA-N N-Hydroxysuccinimide Chemical compound ON1C(=O)CCC1=O NQTADLQHYWFPDB-UHFFFAOYSA-N 0.000 claims description 45
- 238000012360 testing method Methods 0.000 claims description 10
- 239000012086 standard solution Substances 0.000 claims description 6
- 238000002360 preparation method Methods 0.000 claims description 5
- 238000012856 packing Methods 0.000 claims description 2
- 238000000034 method Methods 0.000 abstract description 9
- 238000012545 processing Methods 0.000 abstract description 2
- 239000012074 organic phase Substances 0.000 description 18
- 239000012071 phase Substances 0.000 description 18
- 239000008346 aqueous phase Substances 0.000 description 15
- 238000004132 cross linking Methods 0.000 description 15
- 238000000926 separation method Methods 0.000 description 11
- 239000007788 liquid Substances 0.000 description 9
- 230000014759 maintenance of location Effects 0.000 description 9
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 150000001718 carbodiimides Chemical class 0.000 description 6
- 239000003814 drug Substances 0.000 description 6
- 239000000126 substance Substances 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 239000008213 purified water Substances 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 239000012982 microporous membrane Substances 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 238000011835 investigation Methods 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 2
- 235000019796 monopotassium phosphate Nutrition 0.000 description 2
- 239000012452 mother liquor Substances 0.000 description 2
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 239000012670 alkaline solution Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000012928 buffer substance Substances 0.000 description 1
- 238000010382 chemical cross-linking Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 239000011243 crosslinked material Substances 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical class O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
- 229930027917 kanamycin Natural products 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 229910000403 monosodium phosphate Inorganic materials 0.000 description 1
- 235000019799 monosodium phosphate Nutrition 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000012085 test solution Substances 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
Abstract
Description
有机相 | MES保留时间(min) | NHS保留时间 |
甲醇 | 2.956 | 4.018 |
乙腈 | 2.813 | 3.962 |
流动相组别 | 流动相pH | 配制方法(磷酸盐缓冲液) |
1 | 6.5 | 称取磷酸二氢钾2.8g,加0.1mol/L的氢氧化钠溶液152mL,再稀释至1000mL,微孔滤膜过滤超声待用 |
2 | 5.8 | 取磷酸二氢钾8.34g,和磷酸氢二钾0.87g,定容至1000mL,微孔滤膜过滤超声待用 |
3 | 5.0 | 取0.2mol/L磷酸二氢钠溶液一定量,用氢氧化钠试液调节至pH=5.0,微孔滤膜过滤超声待用 |
峰号 | 保留时间 | 面积 | 高度 |
1 | 2.952 | 1573010 | 252662 |
2 | 4.010 | 118625 | 19121 |
总计 | 1691635 | 271783 |
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410839225.6A CN104407077B (zh) | 2014-12-30 | 2014-12-30 | 一种mes,nhs残留的hplc检测方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410839225.6A CN104407077B (zh) | 2014-12-30 | 2014-12-30 | 一种mes,nhs残留的hplc检测方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104407077A CN104407077A (zh) | 2015-03-11 |
CN104407077B true CN104407077B (zh) | 2016-02-24 |
Family
ID=52644724
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410839225.6A Active CN104407077B (zh) | 2014-12-30 | 2014-12-30 | 一种mes,nhs残留的hplc检测方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104407077B (zh) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104833753B (zh) * | 2015-05-12 | 2017-01-25 | 苏州景卓生物技术有限公司 | Edc残留的hplc‑elsd检测方法 |
CN108226363B (zh) * | 2017-12-04 | 2019-01-18 | 赵欣雨 | 一种利用hplc检测尿激酶分子组分比的方法 |
CN109975440A (zh) * | 2017-12-28 | 2019-07-05 | 江苏众红生物工程创药研究院有限公司 | 一种nhs残留的检测方法 |
CN108982694B (zh) * | 2018-07-27 | 2021-06-29 | 西藏多瑞医药股份有限公司 | 一种n-溴代丁二酰亚胺有关物质的检测方法 |
CN109917121A (zh) * | 2019-03-01 | 2019-06-21 | 洛阳恒恩生物科技有限公司 | 胱抑素c测定试剂盒及其制备方法 |
CN114965761A (zh) * | 2022-05-17 | 2022-08-30 | 深圳赛保尔生物药业有限公司 | 聚乙二醇化蛋白药物中n-羟基琥珀酰亚胺的检测方法 |
CN117491522B (zh) * | 2023-11-03 | 2024-05-07 | 江苏创健医疗科技股份有限公司 | 一种n-羟基琥珀酰亚胺残留量的检测方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101421609A (zh) * | 2006-01-24 | 2009-04-29 | 阿普里拉股份有限公司 | 与分析物测定相关的方法、混合物、试剂盒和组合物 |
WO2009064321A2 (en) * | 2007-11-14 | 2009-05-22 | Ateris Technologies. Llc | Biomarker detection |
-
2014
- 2014-12-30 CN CN201410839225.6A patent/CN104407077B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101421609A (zh) * | 2006-01-24 | 2009-04-29 | 阿普里拉股份有限公司 | 与分析物测定相关的方法、混合物、试剂盒和组合物 |
WO2009064321A2 (en) * | 2007-11-14 | 2009-05-22 | Ateris Technologies. Llc | Biomarker detection |
Non-Patent Citations (4)
Title |
---|
Electrochemical immunoassay of cotinine in serum based on nanoparticle probe and immunochromatographic strip;Hungchi Nian等;《Analytica Chimica Acta》;20121231;第713卷;第50-55页 * |
Synthesizing and binding dual-mode poly (lactic-co-glycolic acid) (PLGA) nanobubbles for cancer targeting and imaging;Jeff S. Xu等;《Biomaterials》;20101231;第31卷;第1716-1722页 * |
用液相芯片技术定量测定人血清 CEA、AFP 和 HBsAg;陈玮等;《中山大学学报(医学科学版)》;20070131;第28卷(第1期);第105-109,114页 * |
靶向血栓 MR 分子探针的构建及初步鉴定;张瑜等;《临床放射学杂志》;20121231;第31卷(第8期);第1178-1182页 * |
Also Published As
Publication number | Publication date |
---|---|
CN104407077A (zh) | 2015-03-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104407077B (zh) | 一种mes,nhs残留的hplc检测方法 | |
CN103760269B (zh) | 一种兽药残留的检测方法 | |
CN105158358A (zh) | 同时检测中成药和保健品中非法添加的42种化学药品的方法 | |
Edlund | Determination of opiates in biological samples by glass capillary gas chromatography with electron-capture detection | |
CN103454360A (zh) | 超滤联合uplc-ms/ms法测定人血浆中游离多西他赛浓度 | |
CN104297406A (zh) | 一种广谱鉴定β-受体激动剂类药物的方法 | |
CN102435680B (zh) | 一种牛血清白蛋白非标记质谱定性、定量检测方法 | |
CN102375033B (zh) | 盐酸苯达莫司汀及其有关物质的高效液相色谱分析方法 | |
CN112782311A (zh) | 一种富马酸丙酚替诺福韦中l-丙氨酸异丙酯的hplc测定方法 | |
CN113092597B (zh) | 一种匹伐他汀钙中间体有关物质的分析方法 | |
CN106033079B (zh) | 甲磺酸达比加群酯起始物料f中有关物质咪唑的检测方法 | |
CN110174470A (zh) | 一种水产品中海洋生物毒素的高通量检测方法 | |
CN110967431B (zh) | 一种高效液相色谱法测定卡托普利片中d-卡托普利和卡托普利有关物质8的方法 | |
CN107345946B (zh) | 用于法庭科学毒品检测的甲卡西酮标准物质的纯化制备方法 | |
CN113671077A (zh) | 丙烯酰氯及其有关物质检测方法 | |
CN107271592A (zh) | 一种盐酸替吡拉西与其相关杂质完全分离的液相色谱纯度检测方法 | |
Joseph et al. | Development and validation of a RP-HPLC method for the estimation of netilmicin sulfate and its related substances using charged aerosol detection | |
CN104634911B (zh) | 一种喘可治注射液4种黄酮类有效成分检测方法 | |
CN103487545A (zh) | 卡巴胆碱及其杂质含量的液相色谱检测方法 | |
CN106018659A (zh) | 一种食品中毒黄素的快速检测方法 | |
CN102565208A (zh) | 一种硫酸依替米星新的检测方法 | |
CN104007185A (zh) | 一种检测扎那米韦及含扎那米韦制剂中杂质的hplc测定方法 | |
CN111044636A (zh) | 米卡芬净含量的分析方法 | |
CN107102081A (zh) | 一种快速筛查鉴别赤潮藻中多种麻痹性贝毒素的方法 | |
CN103487532A (zh) | 一种用液相色谱法分离测定盐酸维拉佐酮原料及其制剂的方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C53 | Correction of patent for invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Yang Zhongke Inventor after: Sun Liman Inventor after: Yang Anshun Inventor after: Jiang Xiaolong Inventor after: Gong Yanming Inventor after: Chen Weiying Inventor after: Ding Xiang Inventor after: Li Juan Inventor after: Li Haoyu Inventor after: Zhang Zhaoli Inventor after: Yang Xiufu Inventor after: Peng Hongwei Inventor before: Yang Zhongke Inventor before: Peng Hongwei Inventor before: Gong Yanming Inventor before: Chen Weiying Inventor before: Ding Xiang Inventor before: Li Juan Inventor before: Li Haoyu Inventor before: Zhang Zhaoli Inventor before: Yang Anshun Inventor before: Jiang Xiaolong |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: YANG ZHONGKE GONG YANMING CHEN WEIYING DING XIANG LI JUAN LI HAOYU ZHANG ZHAOLI YANG ANSHUN JIANG XIAOLONG PENG HONGWEI TO: YANG ZHONGKE GONG YANMING CHEN WEIYING DING XIANG LI JUAN LI HAOYU ZHANG ZHAOLI YANG XIUFU PENG HONGWEI SUN LIMAN YANG ANSHUN JIANG XIAOLONG |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20161230 Address after: 215400 Taicang province Jiangsu city Shaxi town Guizhuang District Road No. 4 Building Xiangtang Zhenhui property Patentee after: Suzhou Jing Zhuo Bioisystech Co., Ltd Address before: Suzhou City, Jiangsu Province, Suzhou Industrial Park 213111 Xinghu Street No. 218 BioBAY A5 building 101-105 unit Patentee before: Suzhou Dapu Biological Technology Co., Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20190821 Address after: 310013 No. 206 Zhenzhong Road, Sandun Town, Xihu District, Hangzhou City, Zhejiang Province Patentee after: Zhejiang Jing Jia Medical Technology Co., Ltd. Address before: 215400 Taicang province Jiangsu city Shaxi town Guizhuang District Road No. 4 Building Xiangtang Zhenhui property Patentee before: Suzhou Jing Zhuo Bioisystech Co., Ltd |